SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 7.47 |
| Enterprise Value ($M) | 150.07 |
| Book Value ($M) | -143.06 |
| Book Value / Share | -1.90 |
| Price / Book | -0.05 |
| NCAV ($M) | -143.06 |
| NCAV / Share | -1.90 |
| Price / NCAV | -0.05 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.46 |
| Return on Assets (ROA) | -0.75 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.74 |
| Current Ratio | 9.74 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 8.90 |
| Assets | 8.90 |
| Liabilities | 151.96 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Soffer Rochel | 10.90 | ||
| 13G/A | Schneid Yair | 19.90 | 0.00 | |
| 13G | ALPHA PHARMA Investments LLC | 5.06 | ||
| 13G/A | Altamont Phamaceutical Holdings, Llc | 0.00 | -100.00 | |
| 13D/A | Sofinnova Venture Partners IX, L.P. | 0.00 | -100.00 | |
| 13G/A | Sectoral Asset Management Inc | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| GNTLF – Genetic Technologies Limited | GPLB – Green Planet Bioengineering Co., Ltd. |
| GRTSQ – Gritstone bio, Inc. | GSAC – GelStat Corp. |
| GSGTF – GenSight Biologics S.A. |
Financial data and stock pages provided by
Fintel.io